Expanding preventive medicine access for mobile groups
Treatments studied
Part of Blood & lymphatic, Eyes & vision, Infections, Skin clinical trials.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child aged 5–14 years or an adult head of household.
- You live permanently or semi-permanently in the study communities.
- You missed one or more past rounds of medicine for river blindness or lymphatic filariasis.
- You are willing to give blood or other samples and take part in interviews or group discussions.
- You (or your parent/guardian, if you are a child) can give permission to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different 3-drug combinations to treat lymphatic filariasis (a parasitic infection that can cause swelling and discomfort). If you live in a participating village, you will get one of these treatments and be monitored for how well it works.
This trial tests whether a combination of medicines works better than a single medicine to treat common intestinal worms (like hookworm and roundworm) in young children in Bangladesh. It is for children who are either stunted (shorter than average for their age) or healthy, and who have a confirmed worm infection.
This trial looks at how active a long-term schistosomiasis infection is in travelers and migrants. It aims to better understand the infection to help guide treatment.
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
This study is testing a new rapid diagnostic test that aims to help eliminate onchocerciasis (river blindness). The test will be checked in people with different types of filarial worm infections (or no infection) to see how well it can tell them apart.
Hear when a new Schistosomiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.